ISRCTN ISRCTN01423159
DOI https://doi.org/10.1186/ISRCTN01423159
Protocol serial number N/A
Sponsor Central and North West London NHS Foundation Trust (UK)
Funder EVIDEM-E is funded as part of a wider programme of Research & Development via the National Institute for Health Research (NIHR) (UK) - Programme Grants for Applied Research (ref: RP-PG-0606-1005)
Submission date
22/04/2009
Registration date
26/05/2009
Last edited
28/08/2018
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Mental and Behavioural Disorders
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr David Lowery
Scientific

Central and North West London NHS Foundation Trust
Greater London House
Hampstead Road
London
NW1 7QY
United Kingdom

Phone +44 (0)20 3214 5889
Email d.lowery@ucl.ac.uk

Study information

Primary study designInterventional
Study designPragmatic single-blind randomised single-centre trial
Secondary study designSingle-centre
Study type Participant information sheet
Scientific titleA randomised controlled evaluation of exercise as a therapy for the behavioural and psychological symptoms of dementia
Study acronymEVIDEM-E
Study objectivesThe introduction of a tailored excercise programme will significantly reduce behavioural and psychological symptoms of dementia.
Ethics approval(s)West London R&D Consortium, submission planned for June 2009 (as of 22/04/2009).
Health condition(s) or problem(s) studiedBehavioural and psychological symptoms of dementia
InterventionA 6-week supervised incremental course of walking outside, at a pace and distance to suit the participant and carer for at least 5 days per week. Walking is a useful exercise which is considered acceptable by participants, and is easily delivered and measured (in terms of time and distance) but rarely incorporated in a daily routine. A physiotherapist or exercise therapist will oversee the delivery of the exercise programme. The sustainability of this intervention will be assessed by evaluating adherence and impact during an unsupervised interval (weeks 6-12) and by further telephone contact at 6 months.

Control group: No exercise training
Intervention typeOther
Primary outcome measure(s)Behavioural and psychological symptoms measured by NPI at baseline, week 6 and 12.
Key secondary outcome measure(s)1. Participants' mental health (General Health Questionnaire) at baseline, week 6 and 12
2. Participants' quality of life (DemQOL-Proxy) at baseline, week 6 and 12
3. Caregivers' burden of caring (short Zarit Caregiver Burden Inventory) at baseline, week 6 and 12
4. Participants' level of physical activity and compliance with the intervention (diaries and heart rate monitors, to be completed by the participant and their carer)
5. Participants' and carers' views about the intervention (Diaries and semi-structured questionnaires to be carried out after the trial)
6. Mortality and domiciliary status at 6 months
Completion date30/04/2011

Eligibility

Participant type(s)Patient
Age groupOther
SexAll
Target sample size at registration145
Key inclusion criteria1. Both males and females, no age limits
2. Diagnosis of:
2.1. Dementia in primary or secondary care OR
2.2. Suspected dementia confirmed by the researcher to ensure the International Classification of Diseases 10th Revision (ICD-10) research criteria for dementia (DCR-10) are met
3. Presence of a carer (professional, friend or family member, who does not necessarily have to live with the participant)
4. Neuropsychiatric Inventory (NPI) score in any one sub-set except only hallucination or delusion more than or equal to 2 in severity and more than or equal to 2 in frequency
5. Consent of participant, or in the case of an individual who is not capable of giving informed consent, the assent of the participant with agreement of carer
6. Consent of carer
Key exclusion criteria1. Cardio-respiratory condition, neurological or musculo-skeletal condition of a degree that prevents participation to even the modified exercise regime unsafe or not possible
2. A score of three or more assessed using the Falls Risk Assessment Tool or less than one minute as assessed by the Timed Unsupported Steady Stand test
3. Uncontrolled medical problems, which the GP considers would exclude participants from undertaking the exercise programme; for example, acute systemic illness such as pneumonia, poorly controlled angina, acute rheumatoid arthritis, unstable or acute heart failure
4. Sensory impairment to an extent that prevents dyad facilitated exercise
5. Participant or carer dissent to engage in the exercise programme
6. Acute confusional state
Date of first enrolment01/08/2009
Date of final enrolment30/04/2011

Locations

Countries of recruitment

  • United Kingdom
  • England

Study participating centre

Central and North West London NHS Foundation Trust
London
NW1 7QY
United Kingdom

Results and Publications

Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/08/2014 Yes No
Results article results 01/04/2015 Yes No
Results article cost-effectiveness results 01/06/2016 Yes No
Protocol article protocol 13/05/2010 Yes No
Participant information sheet Participant information sheet 11/11/2025 11/11/2025 No Yes
Study website Study website 11/11/2025 11/11/2025 No Yes

Editorial Notes

28/08/2018: Publication reference added.